Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)

ClinicalTrials.gov ID: NCT04313153

Public ClinicalTrials.gov record NCT04313153. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3b, Randomized, Open-label, Active-controlled Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)

Study identification

NCT ID
NCT04313153
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Akebia Therapeutics
Industry
Enrollment
319 participants

Conditions and interventions

Conditions

Interventions

  • Vadadustat Drug
  • Darbepoetin alfa Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 26, 2020
Primary completion
Nov 25, 2021
Completion
Jun 21, 2022
Last update posted
May 21, 2025

2020 – 2022

United States locations

U.S. sites
39
U.S. states
16
U.S. cities
34
Facility City State ZIP Site status
Research Site Chula Vista California 91910
Research Site Granada Hills California 91344
Research Site Los Angeles California 90022
Research Site Lynwood California 90262
Research Site Northridge California 91324
Research Site San Dimas California 91773
Research Site Whittier California 90603
Research Site Denver Colorado 80230
Research Site Middlebury Connecticut 06762
Research Site Coral Gables Florida 33134
Research Site Tampa Florida 33614
Research Site Winter Park Florida 32789
Research Site Pontiac Michigan 48341
Research Site Roseville Michigan 48066
Research Site Minneapolis Minnesota 55404
Research Site Brookhaven Mississippi 39601
Research Site Tupelo Mississippi 38801
Research Site Kansas City Missouri 64111
Research Site St Louis Missouri 63136
Research Site Las Vegas Nevada 89128
Research Site Albuquerque New Mexico 87109
Research Site Durham North Carolina 27704
Research Site Kinston North Carolina 28504
Research Site New Bern North Carolina 28562
Research Site Bethlehem Pennsylvania 18017
Research Site Orangeburg South Carolina 29118
Research Site Chattanooga Tennessee 37404
Research Site Knoxville Tennessee 37920
Research Site Knoxville Tennessee 37923
Research Site Austin Texas 78751
Research Site Austin Texas 78758
Research Site El Paso Texas 79902
Research Site Houston Texas 77004
Research Site Houston Texas 77099
Research Site McAllen Texas 78503
Research Site San Antonio Texas 78204
Research Site San Antonio Texas 78212
Research Site San Antonio Texas 78229
Research Site Hampton Virginia 23666

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04313153, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 21, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04313153 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →